We use cookies for a better user experience. Read our Privacy Policy

I Agree

Sleep Apnea Devices Market

Sleep Apnea Devices Market (Diagnostic Device: Actigraphy Systems, Polysomnography [PSG] Devices, Respiratory Polygraph, and Single-channel Screening Devices (Pulse Oximeters) and Therapeutic Device: Airway Clearance Systems, Adaptive Servo-ventilation [ASV], Positive Airway Pressure [PAP] Devices, Oral Appliances, Oxygen Devices, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Sleep Apnea Devices Market Outlook 2028

  • The global sleep apnea devices market was valued at US$ 7 Bn in 2020
  • It is estimated to expand at a CAGR of 8.5% from 2021 to 2028
  • The global sleep apnea devices market is expected to reach the value of US$ 14.7 Bn by the end of 2028

Analysts’ Viewpoint on Sleep Apnea Devices Market Scenario

Several multinational companies and emerging players in the sleep apnea devices market have already started re-evaluating their supply chains and in the process of shuffling their business operations to reduce concentration in a handful of countries during the ongoing COVID-19 pandemic. However, lack of insurance coverage for OSA and its related therapeutic & diagnostic machines and devices are affecting market growth in developing economies such as India. Hence, med-tech companies in the sleep apnea devices market should invest in marketing and advertising to increase the acceptance of these devices among patients. Such trends will encourage insurance companies to provide health coverage for sleep apnea and related comorbidities including OSA.

Collaborative Agreements Help Innovate in Sleep Apnea Devices

Key players in the global sleep apnea devices market are engaged in meeting regulatory approvals, launching technologically advanced products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the sleep apnea devices market. Business expansion strategies adopted by players operating in the global sleep apnea devices market are innovating in 3D printed parts used to convert BiPAP (Bilevel Positive Airway Pressure) machines, generally used to treat sleep apnea or COPD, into ventilators.

Companies are entering into collaboration agreements to bring obstructive sleep apnea (OSA) treatment products directly to customers through sleep clinics in the U.S. They are introducing customizable oral appliance therapy devices, which hold potentials as an alternative to CPAP (continuous positive airway pressure) therapy in the U.S.

Request a sample to get extensive insights into the Sleep Apnea Devices Market

eHealth Holds Potentials for Device Sales Post COVID-19 Pandemic

Telehealth and eHealth mobile apps are anticipated to transform the sleep apnea devices market post the COVID-19 pandemic period. However, participants in the market are addressing disruption for sales since elective medical procedures have been postponed indefinitely. Hence, companies are taking data-driven decisions to map volatile demand trends for sleep apnea devices.

Domestic and global companies are in the midst of rapid shift in supply chain planning, operations, and inventory management to address the impact of the pandemic. Nevertheless, companies are taking advantage of government stimulus packages to stay financially afloat. The demand for sleep apnea devices is projected to increase at a sluggish pace, due to the lockdown being enforced in most countries.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Lack of Insurance Coverage for Sleep Apnea Devices Hampers Market Growth

The most common treatment option for people with sleep apnea are CPAP devices. These machines are available in various sizes and styles. The price varies depending on the brand, type, and features. However, a CPAP machine can cost anywhere from US$ 250 to US$ 1,000 or more at retail. This is hampering market growth. Hence, companies should partner with experts to innovate in devices that are affordable.

On the other hand, in emerging markets such as India, the lack of medical coverage provided by public or private insurance companies tends to restrain the market growth in the region. Dearth of awareness about obstructive sleep apnea in emerging countries is expected to affect market growth during the forecast period. Hence, companies should focus on marketing sleep apnea devices to increase its acceptance, which, in turn, will encourage insurance companies to provide coverage for health issues pertaining to the OSA.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Sleep Apnea Devices Market

High Prevalence of Sleep Apnea Patients Contributes to Market Growth

Sleep disorders, including sleep apnea, have emerged as a major public health concern in the U.S. Sleep apnea affects an estimated 22 million people in the U.S., with 80% of moderate and severe obstructive sleep apnea cases going undiagnosed. This is fueling the need of advertising on sleep apnea devices to make people aware about the serious health risks of OSA.

OSA, which accounts for the majority of cases, can lead to high blood pressure, chronic heart failure, atrial fibrillation, stroke, and other cardiovascular problems if left untreated. It is linked to type 2 diabetes and depression, and is a factor in a number of traffic accidents and accidents involving heavy machinery due to the persistent drowsiness experienced by many OSA patients before the disease is diagnosed and treated. Thus, med-tech companies in the sleep apnea devices market should capitalize on this opportunity to bolster manufacturing capabilities to increase the availability of machines.

Health Risks of OSA Fueling Demand for Sleep Apnea Devices

Obstructive sleep apnea is a prevalent disease wherein people continuously halt or reduce their breathing while sleeping. This leads to restless, fragmented sleep, which could cause symptoms such as morning headaches and daytime lethargy.

OSA affects people of all ages; however, it is more common in people over the age of 60. The precise incidence is unknown; however, it is thought to be between 2% and 14%. Obstructive sleep apnea is linked to a number of health problems, including hypertension, coronary artery disease, cardiac arrhythmias, and depression. Obesity, one of the major sleep apnea risk factors, is on the rise, and contributes to the increase in prevalence of sleep apnea. Such trends are translating into revenue opportunities for med-tech companies in the sleep apnea devices market.

Sleep Apnea Devices Market: Overview

  • According to Transparency Market Research’s latest report on the global sleep apnea devices market for the historical period 2017–2028 and forecast period 2021–2028, rise in demand for home sleep apnea tests (HSATs) is projected to drive the global sleep apnea devices market during the forecast period

Rise in Prevalence of Obstructive Sleep Apnea Disorder (OSA): Key Driver

  • Obstructive sleep apnea is a prevalent disease, in which people continuously halt or reduce their breathing while sleeping. This leads to restless, fragmented sleep, which could cause symptoms such as morning headaches and daytime lethargy.
  • Obstructive sleep apnea affects people of all ages; however, it is more common in people over the age of 60. The precise incidence is unknown; however, it is thought to be between 2% and 14%. Obstructive sleep apnea is linked to a number of health problems including hypertension, coronary artery disease, cardiac arrhythmias, and depression.
  • Obesity, one of the major sleep apnea risk factors, is on the rise, and contributes to the increase in prevalence of sleep apnea

Large Number of Undiagnosed Sleep Apnea Patients

  • Sleep disorders, including sleep apnea, have emerged as a major public health concern in the U.S. Sleep apnea affects an estimated 22 million people in the U.S., with 80 percent of moderate and severe obstructive sleep apnea cases going undiagnosed.
  • OSA, which accounts for the majority of cases, can lead to high blood pressure, chronic heart failure, atrial fibrillation, stroke, and other cardiovascular problems if left untreated. It is linked to type 2 diabetes and depression, and is a factor in a number of traffic accidents and accidents involving heavy machinery due to the persistent drowsiness experienced by many OSA patients before the disease is recognized and treated.

High Cost of Sleep Apnea Devices

  • The most common treatment option for people with sleep apnea is continuous positive airway pressure (CPAP) device
  • These machines are available in various sizes and styles. The price varies depending on the brand, type, and features. A CPAP machine can cost anywhere from US$ 250 to US$ 1,000 or more at retail.
  • Similarly, in emerging markets such as India, the lack of medical coverage provided by public or private insurance companies restrains the market in the region
  • Lack of awareness about obstructive sleep apnea (OSA) in emerging countries is expected to hamper market growth during the forecast period

Sleep Apnea Devices Market: Competition Landscape

  • This report profiles major players in the global sleep apnea devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global sleep apnea devices market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global sleep apnea devices market are
    • ResMed, Inc.
    • BMC Medical Co., Ltd.
    • Braebon Medical Corporation
    • Compumedics Limited
    • Devilbiss Healthcare LLC
    • Fisher & Paykel Healthcare Limited
    • Koninklijke Philips N.V.
    • Löwenstein Group
    • Oventus Medical
    • Panthera Dental
    • SomnoMed Limited
    • Whole You (Subsidiary of Mitsui Chemicals, Inc.), among others

Sleep Apnea Devices Market: Key Developments

  • Key players in the global sleep apnea devices market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global sleep apnea devices market. A few expansion strategies adopted by players operating in the global sleep apnea devices market are:
    • In March 2020, Northwell Health (US) used 3D printed parts to convert BiPAP machines, which are generally used to treat sleep apnea or COPD, into ventilators
    • In June 2021, Oventus Medical and Aeroflow Healthcare entered into a collaboration agreement to bring Oventus' obstructive sleep apnea (OSA) treatment products, notably O2Vent Optima, directly to customers through sleep clinics in the U.S.
    • In February 2021, Oventus Medical introduced 02Vent Optima, a customizable oral appliance therapy device, which, through GoPAPfree, provides an alternative to CPAP therapy in the U.S.
  • The report on the global sleep apnea devices market discusses individual strategies, followed by company profiles of manufacturers of sleep apnea devices. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global sleep apnea devices market.

Sleep Apnea Devices Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 7 Bn

Market Forecast Value in 2028

US$ 14.7 Bn

Growth Rate (CAGR)

8.5%

Forecast Period

2021–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • By Diagnostic Device
    • Actigraphy Systems
    • Polysomnography (PSG) Devices
    • Respiratory Polygraph
    • Single-Channel Screening Devices (Pulse Oximeters)
  • By Therapeutic Device
    • Airway Clearance Systems
    • Adaptive Servo-Ventilation (ASV)
    • Positive Airway Pressure (PAP) Devices
    • Oral Appliances
    • Oxygen Devices
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • ResMed, Inc.
  • BMC Medical Co., Ltd.
  • Braebon Medical Corporation
  • Compumedics Limited
  • Devilbiss Healthcare LLC
  • Fisher & Paykel Healthcare Limited
  • Koninklijke Philips N.V.
  • Löwenstein Group
  • Oventus Medical
  • Panthera Dental
  • SomnoMed Limited
  • Whole You (subsidiary of Mitsui Chemicals, Inc.)
  • Other prominent players

Customization Scope

Available upon request

Pricing

Available upon request

Sleep Apnea Devices Market – Segmentation

Diagnostic Device
  • Actigraphy Systems
  • Polysomnography (PSG) Devices
  • Respiratory Polygraph
  • Single-channel Screening Devices (Pulse Oximeters)
Therapeutic Device
  • Airway Clearance Systems
  • Adaptive Servo-ventilation (ASV)
  • Positive Airway Pressure (PAP) Devices
  • Oral Appliances
  • Oxygen Devices
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of sleep apnea devices market?

Sleep apnea devices market is expected to reach the value of US$ 14.7 Bn by the end of 2028

What is the anticipated CAGR of the sleep apnea devices market in the forecast period?

Sleep apnea devices market is estimated to expand at a CAGR of 8.5% from 2021 to 2028

What are the key driving factors for the growth of the sleep apnea devices market?

Sleep apnea devices market is driven by rise in demand for home sleep apnea tests (HSATs), increase in need of diagnostic tests, and high adoption of sleep apnea devices

Which is the rising prominent segment in the sleep apnea devices market?

The polysomnography (PSG) devices segment accounted for a major share of the global sleep apnea devices market

Who are the key players in the global sleep apnea devices market?

Key players in the global market include ResMed, Inc., BMC Medical Co., Ltd., Braebon Medical Corporation, Compumedics Limited, Devilbiss Healthcare LLC, Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Sleep Apnea Devices Market

4. Market Overview

    4.1. Introduction

        4.1.1. Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Sleep Apnea Devices Market Analysis and Forecast, 2017–2028

5. Key Insights

    5.1. Technological Advancements

    5.2. Regulatory Scenario by Region/globally

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemics Impact on Industry

6. Global Sleep Apnea Devices Market Analysis and Forecast, by Diagnostic Device

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Diagnostic Device, 2017–2028

        6.3.1. Actigraphy Systems

        6.3.2. Polysomnography (PSG) Devices

        6.3.3. Respiratory Polygraph

        6.3.4. Single-channel Screening Devices (pulse oximeters)

    6.4. Market Attractiveness Analysis, by Diagnostic Device

7. Global Sleep Apnea Devices Market Analysis and Forecast, by Therapeutic Device

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Therapeutic Device, 2017–2028

        7.3.1. Airway Clearance Systems

        7.3.2. Adaptive Servo-Ventilation (ASV)

        7.3.3. Positive Airway Pressure (PAP) Devices

        7.3.4. Oral Appliances

        7.3.5. Oxygen Devices

        7.3.6. Others

    7.4. Market Attractiveness Analysis, by Therapeutic Device

8. Global Sleep Apnea Devices Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, by Country/Region

9. North America Sleep Apnea Devices Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Diagnostic Device, 2017–2028

        9.2.1. Actigraphy Systems

        9.2.2. Polysomnography (PSG) Device

        9.2.3. Respiratory Polygraph

        9.2.4. Single-Channel Screening Devices (pulse oximeters)

    9.3. Market Value Forecast, by Therapeutic Device, 2017–2028

        9.3.1. Airway Clearance Systems

        9.3.2. Adaptive Servo-Ventilation (ASV)

        9.3.3. Positive Airway Pressure (PAP) Devices

        9.3.4. Oral Appliances

        9.3.5. Oxygen Devices

        9.3.6. Others

    9.4. Market Value Forecast, by Country, 2017–2028

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Diagnostic Device

        9.5.2. By Therapeutic Device

        9.5.3. By Country

10. Europe Sleep Apnea Devices Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Diagnostic Device, 2017–2028

        10.2.1. Actigraphy Systems

        10.2.2. Polysomnography (PSG) Devices

        10.2.3. Respiratory Polygraph

        10.2.4. Single-Channel Screening Devices (pulse oximeters)

    10.3. Market Value Forecast, by Therapeutic Device, 2017–2028

        10.3.1. Airway Clearance Systems

        10.3.2. Adaptive Servo-Ventilation (ASV)

        10.3.3. Positive Airway Pressure (PAP) Devices

        10.3.4. Oral Appliances

        10.3.5. Oxygen Devices

        10.3.6. Others

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2028

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Italy

        10.4.5. Spain

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Diagnostic Device

        10.5.2. By Therapeutic Device

        10.5.3. By Country/Sub-region

11. Asia Pacific Sleep Apnea Devices Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Diagnostic Device, 2017–2028

        11.2.1. Actigraphy Systems

        11.2.2. Polysomnography (PSG) Devices

        11.2.3. Respiratory Polygraph

        11.2.4. Single-Channel Screening Devices (pulse oximeters)

    11.3. Market Value Forecast, by Therapeutic Device, 2017–2028

        11.3.1. Airway Clearance Systems

        11.3.2. Adaptive Servo-Ventilation (ASV)

        11.3.3. Positive Airway Pressure (PAP) Devices

        11.3.4. Oral Appliances

        11.3.5. Oxygen Devices

        11.3.6. Others

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2028

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. By Diagnostic Device

        11.5.2. By Therapeutic Device

        11.5.3. By Country/Sub-region

12. Latin America Sleep Apnea Devices Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Diagnostic Device, 2017–2028

        12.2.1. Actigraphy Systems

        12.2.2. Polysomnography (PSG) Devices

        12.2.3. Respiratory Polygraph

        12.2.4. Single-Channel Screening Devices (pulse oximeters)

    12.3. Market Value Forecast, by Therapeutic Device, 2017–2028

        12.3.1. Airway Clearance Systems

        12.3.2. Adaptive Servo-Ventilation (ASV)

        12.3.3. Positive Airway Pressure (PAP) Devices

        12.3.4. Oral Appliances

        12.3.5. Oxygen Devices

        12.3.6. Others

    12.4. Market Value Forecast, by Country/Sub-region, 2017–2028

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis

        12.5.1. By Diagnostic Device

        12.5.2. By Therapeutic Device

        12.5.3. By Country/Sub-region

13. Middle East & Africa Sleep Apnea Devices Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Diagnostic Device, 2017–2028

        13.2.1. Actigraphy Systems

        13.2.2. Polysomnography (PSG) Devices

        13.2.3. Respiratory Polygraph

        13.2.4. Single-Channel Screening Devices (pulse oximeters)

    13.3. Market Value Forecast, by Therapeutic Device, 2017–2028

        13.3.1. Airway Clearance Systems

        13.3.2. Adaptive Servo-Ventilation (ASV)

        13.3.3. Positive Airway Pressure (PAP) Devices

        13.3.4. Oral Appliances

        13.3.5. Oxygen Devices

        13.3.6. Others

    13.4. Market Value Forecast, by Country/Sub-region, 2017–2028

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis

        13.5.1. By Diagnostic Device

        13.5.2. By Therapeutic Device

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by tier and size of companies)

    14.2. Market Share Analysis, by Company, 2020

    14.3. Company Profiles

        14.3.1. CareFusion Corporation

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Financial Analysis

            14.3.1.3. Growth Strategies

            14.3.1.4. SWOT Analysis

        14.3.2. Fisher & Paykel Healthcare

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Financial Analysis

            14.3.2.3. Growth Strategies

            14.3.2.4. SWOT Analysis

        14.3.3. GE Healthcare

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Financial Analysis

            14.3.3.3. Growth Strategies

            14.3.3.4. SWOT Analysis

        14.3.4. ImThera Medical, Inc.

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Financial Analysis

            14.3.4.3. Growth Strategies

            14.3.4.4. SWOT Analysis

        14.3.5. Philips Healthcare

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Financial Analysis

            14.3.5.3. Growth Strategies

            14.3.5.4. SWOT Analysis

        14.3.6. ResMed, Inc.

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Financial Analysis

            14.3.6.3. Growth Strategies

            14.3.6.4. SWOT Analysis

        14.3.7. Teleflex, Inc.

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Financial Analysis

            14.3.7.3. Growth Strategies

            14.3.7.4. SWOT Analysis

List of Tables

Table 1: Market Snapshot: Global Sleep Apnea Devices Market, 2017 and 2028

Table 2: Percentage of Registered Studies by Location

Table 3: Share of Total Global R&D Spending

Table 4: Global Sleep Apnea Devices Market Revenue (US$ Mn), by Diagnostic, 2021–2028

Table 5: Global Sleep Apnea Devices Market Revenue (US$ Mn), by Therapeutic Device, 2021–2028

Table 6: Global Sleep Apnea Devices Market Revenue (US$ Mn), by Region/country, 2021–2028

Table 7: North America Sleep Apnea Devices Market Revenue (US$ Mn), by Diagnostic Device, 2021–2028

Table 8: North America Sleep Apnea Devices Market Revenue (US$ Mn), by Therapeutic Device, 2021–2028

Table 9: Europe Sleep Apnea Devices Market Revenue (US$ Mn), by Diagnostic Device, 2021–2028

Table 10: Europe Sleep Apnea Devices Market Revenue (US$ Mn), by Therapeutic Device, 2021–2028

Table 11: Europe Sleep Apnea Devices Market Revenue (US$ Mn), by Country/Sub-region, 2021–2028

Table 12: Asia Pacific Sleep Apnea Devices Market Revenue (US$ Mn), by Diagnostic Device, 2021–2028

Table 13: Asia Pacific Sleep Apnea Devices Market Revenue (US$ Mn), by Therapeutic Device, 2021–2028

Table 14: Asia Pacific Sleep Apnea Devices Market Revenue (US$ Mn), by Country/Sub-region, 2021–2028

Table 15: Latin America Sleep Apnea Devices Market Revenue (US$ Mn), by Diagnostic Device, 2021–2028

Table 16: Latin America Sleep Apnea Devices Market Revenue (US$ Mn), by Therapeutic Device, 2021–2028

Table 17: Latin America Sleep Apnea Devices Market Revenue (US$ Mn), by Country/Sub-region, 2021–2028

Table 18: Middle East and Africa Sleep Apnea Devices Market Revenue (US$ Mn), by Diagnostic Device, 2021–2028

Table 19: Middle East and Africa Sleep Apnea Devices Market Revenue (US$ Mn), by Therapeutic Device, 2021–2028

Table 20: Middle East and Africa Sleep Apnea Devices Market Revenue (US$ Mn), by Country/Sub-region, 2021–2028

List of Figures

Figure 1: Market Segmentation: Sleep Apnea Devices Market

Figure 2: Porter’s Five Forces Analysis: Sleep Apnea Devices Market

Figure 3: Value Chain Analysis: Sleep Apnea Devices Market

Figure 4: Market Attractiveness Analysis: Sleep Apnea Devices Market

Figure 5: Global Sleep Apnea Devices Market (US$ Mn), by Diagnostic and Therapeutic Devices, 2017 and 2028

Figure 6: North America Sleep Apnea Devices Market Share (Value %), by Region, 2017 and 2028 

Figure 7: Europe Sleep Apnea Devices Market Share (Value %), by Region, 2017 and 2028

Figure 8: Asia Pacific Sleep Apnea Devices Market Share (Value %), by Region, 2017 and 2028

Figure 9: Latin America Sleep Apnea Devices Market Share (Value %), by Region, 2017 and 2028

Figure 10: Middle East and Africa Sleep Apnea Devices Market Share (Value %), by Region, 2017 and 2028

Figure 11: Competitive Landscape: Sleep Apnea Devices Market

Figure 12: Global Sleep Apnea Devices Market Revenue (US$ Mn), 2021–2028

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

495

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved